当前位置： SCI文献检索 > BLOOD期刊下所有文献 > Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease.

Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease.

Abstract：

:A case of acute lymphoblastic leukemia (ALL) was encountered in which the two clonal gamma T-cell receptor gene (TCR gamma) rearrangements found in bone marrow (BM) samples at relapse both differed from the single clonal TCR gamma rearrangement present in BM obtained at diagnosis 5 years previously. In contrast, two clonal Ig heavy chain gene (IgH) rearrangements present at relapse were identical to those present at diagnosis. Comparison of the DNA sequences of the relapse TCR gamma rearrangements with that of the diagnostic TCR gamma rearrangement indicated that they must have been generated de novo from TCR gamma loci in germline configuration. By polymerase chain reaction using clonotypic N-region oligonucleotide primers (N-PCR), cells bearing the diagnosis or relapse TCR gamma rearrangements were undetectable in the sample from the opposite time point. Two BM samples obtained at different times in clinical remission were both devoid of detectable residual tumor when analyzed by N-PCR, indicating a depth of remission of less than 1 tumor cell per 4 x 10(5) BM mononuclear cells. The tumor cells showed a primitive phenotype: T-cell antigen-negative, CALLA/CD10-negative, CD20-negative, CD19-positive, and positive for the myeloid marker My9. This case, which appears to represent a tumor arising from a progenitor cell with both early B-lineage and certain stem cell features, has implications for monitoring residual ALL and possibly also for treatment of the disease.

journal_name

Blood

journal_title

Blood

authors

Tycko B,Ritz J,Sallan S,Sklar J

subject

Has Abstract

pub_date

1992-01-15 00:00:00

pages

481-8

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

79

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation.

    abstract：:To obtain information relevant to the question of bone marrow transplantation, we examined the prognostic significance of disease features recorded at the time of diagnosis among 625 patients, aged 5 to 45, with Philadelphia chromosome-positive, nonblastic chronic granulocytic leukemia. The actuarial death rate for th...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Sokal JE,Baccarani M,Tura S,Fiacchini M,Cervantes F,Rozman C,Gomez GA,Galton DA,Canellos GP,Braun TJ

    更新日期：1985-12-01 00:00:00

  • Eastern European (delta beta) zero-thalassemia: molecular characterization of a novel 9.1-kb deletion resulting in high levels of fetal hemoglobin in the adult.

    abstract：:A novel deletion in the human beta-globin gene cluster associated with increased levels of fetal hemoglobin (HbF) in adult life was molecularly characterized in a member of a family of Eastern European descent. The phenotype of the deletion, documented in five members of the family, shows mild hypochromia and microcyt...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Palena A,Blau A,Stamatoyannopoulos G,Anagnou NP

    更新日期：1994-06-15 00:00:00

  • Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse.

    abstract：:Laromustine is a sulfonylhdrazine alkylator with significant antileukemia activity. An international, randomized (2:1), double-blind, placebo-controlled study was conducted to compare complete remission (CR) rates and overall survival (OS) in patients with first relapse acute myeloid leukemia (AML) treated with laromu...

    journal_title：Blood

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1182/blood-2009-06-229351

    authors： Giles F,Vey N,DeAngelo D,Seiter K,Stock W,Stuart R,Boskovic D,Pigneux A,Tallman M,Brandwein J,Kell J,Robak T,Staib P,Thomas X,Cahill A,Albitar M,O'Brien S

    更新日期：2009-11-05 00:00:00

  • Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia.

    abstract：:Allelic loss at nonrandom chromosomal sites is thought to mark the position of tumor suppressor genes involved in the pathogenesis and progression of human malignancies. Solid tumors in particular have been found to harbor multiple genetic changes resulting in loss of function mutations. Tumor suppressor genes have al...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Bullrich F,Veronese ML,Kitada S,Jurlander J,Caligiuri MA,Reed JC,Croce CM

    更新日期：1996-10-15 00:00:00

  • Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia.

    abstract：:Autologous bone marrow transplantation (ABMT) makes it possible to escalate the dose of cytotoxic treatment to a lethal range. Disease-free survival (DFS) following myeloablative therapy and ABMT has been shown to be superior to conventional treatment in high risk patients with acute myelogenous leukemia (AML). It was...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Körbling M,Hunstein W,Fliedner TM,Cayeux S,Dörken B,Fehrentz D,Haas R,Ho AD,Keilholz U,Knauf W

    更新日期：1989-11-01 00:00:00

  • Thrombosis in primary myelofibrosis: incidence and risk factors.

    abstract：:We assessed frequency and predictive factors for major cardiovascular (CV) events in 707 patients with primary myelofibrosis (PMF) followed in 4 European institutions. A total of 236 deaths (33%) were recorded for an overall mortality of 7.7% patient-years (pt-yr). Fatal and nonfatal thromboses were registered in 51 (...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-08-238956

    authors： Barbui T,Carobbio A,Cervantes F,Vannucchi AM,Guglielmelli P,Antonioli E,Alvarez-Larrán A,Rambaldi A,Finazzi G,Barosi G

    更新日期：2010-01-28 00:00:00

  • Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

    abstract：:Adult T-cell leukemia (ATL) and human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are known to be caused by HTLV-I infection. However, current methods used to determine HTLV-I infection do not differentiate between HTLV-I asymptomatic carriers (ACs) and ATL an...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-11-390807

    authors： Enose-Akahata Y,Abrams A,Johnson KR,Maloney EM,Jacobson S

    更新日期：2012-03-22 00:00:00

  • Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishin

    abstract：:The purpose of this study was to compare transplantation outcomes in patients with hematologic malignancies who received marrow grafts from either phenotypically matched unrelated, one-antigen-mismatched unrelated, or highly human leukocyte antigen (HLA)-disparate family donors. Between 1993 and 2000, 139 patients und...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.v99.3.806

    authors： Drobyski WR,Klein J,Flomenberg N,Pietryga D,Vesole DH,Margolis DA,Keever-Taylor CA

    更新日期：2002-02-01 00:00:00

  • A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

    abstract：:The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis, but little is known on progression or reversibility of renal involvement, and criteria for renal response have never been validated. Newly diagnosed patients from the Pavia (n = 461, testing cohort) and Heidelberg (n = 271, val...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2014-04-570010

    authors： Palladini G,Hegenbart U,Milani P,Kimmich C,Foli A,Ho AD,Vidus Rosin M,Albertini R,Moratti R,Merlini G,Schönland S

    更新日期：2014-10-09 00:00:00

  • Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study.

    abstract：:Antibody-induced antigenic modulation (AIAM) of CD10 and CD19 was studied on NALM-6, RAJI, and JOK-1 cell lines using fluorescence microscopy (FM), flow cytometry (FCM), and immunoelectron microscopy (IEM). Cross-linking with monoclonal antibodies (MoAbs) induced rapid redistribution of CD10 and CD19 on the cell surfa...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Pulczynski S,Boesen AM,Jensen OM

    更新日期：1993-03-15 00:00:00

  • Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

    abstract：:Silent cerebral infarct (SCI) is the most common form of neurologic disease in children with sickle cell anemia (SCA). SCI is defined as abnormal magnetic resonance imaging (MRI) of the brain in the setting of a normal neurologic examination without a history or physical findings associated with an overt stroke. SCI o...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：10.1182/blood-2011-02-272682

    authors： DeBaun MR,Armstrong FD,McKinstry RC,Ware RE,Vichinsky E,Kirkham FJ

    更新日期：2012-05-17 00:00:00

  • Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin.

    abstract：:Karyotypes in multiple myeloma (MM) are complex and exhibit numerous structural and numerical aberrations. The largest subset of structural chromosome anomalies in clinical specimens and cell lines involves aberrations of chromosome 1. Unbalanced translocations and duplications involving all or part of the whole long ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Sawyer JR,Tricot G,Mattox S,Jagannath S,Barlogie B

    更新日期：1998-03-01 00:00:00

  • Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease.

    abstract：:The nature of Reed-Sternberg cells, the abnormal cells of Hodgkin's disease, is controversial. Morphological and immunologic marker studies suggested different cells of origin. To investigate a possible B or T cell origin, immunoglobulin and T cell receptor gene analyses were performed on tissues from 11 patients in e...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Brinker MG,Poppema S,Buys CH,Timens W,Osinga J,Visser L

    更新日期：1987-07-01 00:00:00

  • Impaired granulocyte superoxide production and prolongation of the respiratory burst due to a low-affinity NADPH-dependent oxidase.

    abstract：:A 7-yr-old girl with self-limited pulmonary aspergillosis was found to have a defect in granulocyte superoxide production. Her cells produced superoxide at 3% of control rates in response to phorbol myristate acetate (PMA) and opsonized zymosan. Lag times for O-2 production were normal with PMA, opsonized zymosan, and...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Shurin SB,Cohen HJ,Whitin JC,Newburger PE

    更新日期：1983-09-01 00:00:00

  • Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes.

    abstract：:Fanconi anemia (FA) is a genetic disease characterized by congenital abnormalities, bone marrow failure, and susceptibility to leukemia and other cancers. FANCJ, one of 13 genes linked to FA, encodes a DNA helicase proposed to operate in homologous recombination repair and replicational stress response. The pathogenic...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-11-256016

    authors： Wu Y,Sommers JA,Suhasini AN,Leonard T,Deakyne JS,Mazin AV,Shin-Ya K,Kitao H,Brosh RM Jr

    更新日期：2010-11-11 00:00:00

  • Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor.

    abstract：:The interaction of von Willebrand factor (vWF) with the alpha v beta 3 integrin of human umbilical vein endothelial cells is dependent on the RGD sequence present at residues 1744-1746 of the mature vWF subunit. We compared vWF and its two dimeric fragments, SpIII (residues 1-1365) and SpII (residues 1366-2050), as ad...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Denis C,Williams JA,Lu X,Meyer D,Baruch D

    更新日期：1993-12-15 00:00:00

  • Clonal competition with alternating dominance in multiple myeloma.

    abstract：:Emerging evidence indicates that tumors can follow several evolutionary paths over a patient's disease course. With the use of serial genomic analysis of samples collected at different points during the disease course of 28 patients with multiple myeloma, we found that the genomes of standard-risk patients show few ch...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2012-01-405985

    authors： Keats JJ,Chesi M,Egan JB,Garbitt VM,Palmer SE,Braggio E,Van Wier S,Blackburn PR,Baker AS,Dispenzieri A,Kumar S,Rajkumar SV,Carpten JD,Barrett M,Fonseca R,Stewart AK,Bergsagel PL

    更新日期：2012-08-02 00:00:00

  • The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells.

    abstract：:The novel immunosuppressant FTY720 activates sphingosine 1-phosphate receptors (S1PRs) that affect responsiveness of lymphocytes to chemokines such as stromal cell-derived factor 1 (SDF-1), resulting in increased lymphocyte homing to secondary lymphoid organs. Since SDF-1 and its receptor CXCR4 are also involved in bo...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2003-03-0875

    authors： Kimura T,Boehmler AM,Seitz G,Kuçi S,Wiesner T,Brinkmann V,Kanz L,Möhle R

    更新日期：2004-06-15 00:00:00

  • Inflammation rapidly reorganizes mouse bone marrow B cells and their environment in conjunction with early IgM responses.

    abstract：:Systemic inflammation perturbs the bone marrow environment by evicting resident B cells and favoring granulopoiesis over lymphopoiesis. Despite these conditions, a subset of marrow B cell remains to become activated and produce potent acute immunoglobulin M (IgM) responses. This discrepancy is currently unresolved and...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2015-03-635805

    authors： Moreau JM,Berger A,Nelles ME,Mielnik M,Furlonger C,Cen SY,Besla R,Robbins CS,Paige CJ

    更新日期：2015-09-03 00:00:00

  • Studies of factor IX concentrate therapy in hemophilia.

    abstract：:The effects of factor IX concentrate therapy on hemostasis in hemophilia patients were studied by means of the radiometric factor IXa assay, the coupled amidolytic assay for factor VIIa, and coagulant assays for factors II, IX, and X, and antithrombin III. Both activated and unactivated concentrates contained factors ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Hultin MB

    更新日期：1983-09-01 00:00:00

  • Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells.

    abstract：:Interleukin-3 (IL-3) regulates growth and differentiation of multipotential as well as lineage-committed progenitor cells. The human IL-3 receptor (IL-3R) consists of the alpha and common beta (beta c) subunits. The alpha subunit (IL-3R alpha) is specific for IL-3 and binds IL-3 with low affinity. In contrast, the bet...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Sato N,Caux C,Kitamura T,Watanabe Y,Arai K,Banchereau J,Miyajima A

    更新日期：1993-08-01 00:00:00

  • Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib.

    abstract：:The Bernard-Soulier syndrome is an inherited bleeding disorder that is due to a deficiency in platelet glycoprotein Ib. Bernard-Soulier platelets fail to agglutinate in response to ristocetin despite normal levels of factor VIII:von Willebrand factor. We report a patient who developed severe refractory thrombocytopeni...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Devine DV,Currie MS,Rosse WF,Greenberg CS

    更新日期：1987-08-01 00:00:00

  • Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

    abstract：:Polycythemia vera (PV) is a clonal myeloproliferative disorder characterized by excessive erythrocyte production. Most patients with PV harbor an activating JAK2 mutation, but the molecular links between this mutation and erythrocyte overproduction are unknown. The interaction between death receptors and their ligands...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2005-07-3037

    authors： Zeuner A,Pedini F,Signore M,Ruscio G,Messina C,Tafuri A,Girelli G,Peschle C,De Maria R

    更新日期：2006-05-01 00:00:00

  • Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors.

    abstract：:Outgrowth, long-term self-renewal, and terminal maturation of human erythroid progenitors derived from umbilical cord blood in serum-free medium can be modulated by steroid hormones. Homogeneous erythroid cultures, as characterized by flow cytometry and dependence on a specific mixture of physiologic proliferation fac...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2004-03-1002

    authors： Leberbauer C,Boulmé F,Unfried G,Huber J,Beug H,Müllner EW

    更新日期：2005-01-01 00:00:00

  • Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.

    abstract：:We describe the cloning and characterization of Siglec-H, a novel murine CD33-related siglec-like molecule with 2 immunoglobulin domains. Unlike other CD33-related siglecs, Siglec-H lacks tyrosine-based signaling motifs in its cytoplasmic tail. Although Siglec-H has the typical structural features required for sialic ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2005-09-3842

    authors： Zhang J,Raper A,Sugita N,Hingorani R,Salio M,Palmowski MJ,Cerundolo V,Crocker PR

    更新日期：2006-05-01 00:00:00

  • Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

    abstract：:Sickle cell disease is a common hemolytic disorder with a broad range of complications, including vaso-occlusive episodes, acute chest syndrome (ACS), pain, and stroke. Heme oxygenase-1 (gene HMOX1; protein HO-1) is the inducible, rate-limiting enzyme in the catabolism of heme and might attenuate the severity of outco...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-06-361642

    authors： Bean CJ,Boulet SL,Ellingsen D,Pyle ME,Barron-Casella EA,Casella JF,Payne AB,Driggers J,Trau HA,Yang G,Jones K,Ofori-Acquah SF,Hooper WC,DeBaun MR

    更新日期：2012-11-01 00:00:00

  • Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

    abstract：:We investigated whether atorvastatin (AT) was capable of protecting animals from acute graft-versus-host disease (aGVHD) across major histocompatibility complex (MHC) mismatch barriers. AT treatment of the donor induced a Th-2 cytokine profile in the adoptively transferred T cells and reduced their in vivo expansion, ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-08-106005

    authors： Zeiser R,Youssef S,Baker J,Kambham N,Steinman L,Negrin RS

    更新日期：2007-12-15 00:00:00

  • A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax.

    abstract：:Currently, there are no reliable RBC invasion assays to guide the discovery of vaccines against Plasmodium vivax, the most prevalent malaria parasite in Asia and South America. Here we describe a protocol for an ex vivo P vivax invasion assay that can be easily deployed in laboratories located in endemic countries. Th...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-04-348748

    authors： Russell B,Suwanarusk R,Borlon C,Costa FT,Chu CS,Rijken MJ,Sriprawat K,Warter L,Koh EG,Malleret B,Colin Y,Bertrand O,Adams JH,D'Alessandro U,Snounou G,Nosten F,Rénia L

    更新日期：2011-09-29 00:00:00

  • Translation of the Philadelphia chromosome into therapy for CML.

    abstract：:Throughout its history, chronic myeloid leukemia (CML) has set precedents for cancer research and therapy. These range from the identification of the first specific chromosomal abnormality associated with cancer to the development of imatinib as a specific, targeted therapy for the disease. The successful development ...

    journal_title：Blood

    pub_type： 历史文章,杂志文章,评审

    doi：10.1182/blood-2008-07-077958

    authors： Druker BJ

    更新日期：2008-12-15 00:00:00

  • Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.

    abstract：:Chronic graft-versus-host disease (cGVHD) remains a major complication following allogeneic bone marrow transplantation (BMT). The discovery of novel therapeutics is dependent on assessment in preclinical murine models of cGVHD. Rho-associated kinase 2 (ROCK2) recently was shown to be implicated in regulation of inter...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2015-10-678706

    authors： Flynn R,Paz K,Du J,Reichenbach DK,Taylor PA,Panoskaltsis-Mortari A,Vulic A,Luznik L,MacDonald KK,Hill GR,Nyuydzefe MS,Weiss JM,Chen W,Trzeciak A,Serody JS,Aguilar EG,Murphy WJ,Maillard I,Munn D,Koreth J,Cutler CS

    更新日期：2016-04-28 00:00:00